People with common allergies, such as to food, pollen or pets, are no more likely than the rest of the population to have a rare allergic reaction to the COVID-19 vaccine, according to experts.
Two U.S. health care workers had allergic reactions – one of them a serious reaction – after receiving the Pfizer-BioNTech COVID-19 vaccine this week, CBS News reported on Thursday. In Britain, two National Health Services workers had severe allergic reactions after receiving the vaccine earlier this month.
Health Canada has recommended that anyone who is allergic to any of the ingredients should not receive the vaccine. It also advised that anyone who has had a serious allergic reaction to another vaccine, drug or food to talk to their health professional beforehand.
The likelihood of having an allergic reaction to any of the components of the vaccine, however, is extremely rare, said Tim Vander Leek, president of the Canadian Society of Allergy and Clinical Immunology.
“If anybody thinks that they may have a reason not to receive a vaccine like the Pfizer vaccine, I think it’s very important that they discuss that with their health care provider, as opposed to just avoiding it,” he said.
What caused the allergic reactions in the healthcare workers?
The answer is yet unknown. The allergen, or the substance that triggered the allergic reaction, in the two British cases is still under investigation, according to an e-mail from Britain’s Medicines and Healthcare products Regulatory Agency (MHRA).
“One theory is that it may have been the Polyethylene glycol (PEG), but this is not yet proven,” it said.
According to the BBC, both individuals have a history of serious allergies and both were reportedly recovering well the day after receiving the vaccine.
In the U.S. cases, both of which occurred at the same hospital in Juneau, Alaska, one male worker experienced eye puffiness, light-headedness and a scratchy throat minutes after receiving the vaccine on Wednesday, while a female worker showed signs of an anaphylactic reaction on Tuesday, including increased heart rate, shortness of breath, and a skin rash, CBS News reported. Both were treated, and their reactions were not life-threatening. The specific allergen was not reported.
Story continues below advertisement
What is polyethylene glycol?
Polyethylene glycol is a compound used in some medicines, cosmetics and foods, the MHRA said. This ingredient has been identified by Canada’s National Advisory Committee on Immunization as a potential allergen in the Pfizer-BioNTech vaccine.
It is unknown exactly how many people are allergic to PEG, since these allergies may not always be recognized, but research suggests it is extremely rare, Dr. Vander Leek said. For example, he noted in one review of all available medical literature between 1977 and 2016, only 37 cases of allergies to PEG were reported.
In a statement issued on Tuesday, the Canadian Society of Allergy and Clinical Immunology said PEG is found in multiple products that are tolerated safely on a daily basis by many individuals in Canada.
Like the Pfizer-BioNTech vaccine, the Moderna COVID-19 vaccine, which is expected to receive Health Canada approval soon, also contains PEG, so it is likely that the same recommendations – to not receive that vaccine if people have a known allergy to PEG or any other of the vaccine’s ingredients – will apply, Dr. Vander Leek said. However, he added, it is important to note that there are many different types of PEG molecules, and the molecules listed as ingredients in these two vaccines are different. Individuals with an allergy to one type of PEG may be able to tolerate another form of it, he said, noting this underscores the importance of consulting a health care provider.
What other ingredients are in the vaccine?
Story continues below advertisement
The medicinal ingredient in the Pfizer-BioNTech vaccine is mRNA. Besides PEG, other non-medical ingredients are as follows: ALC-0315 = ((4-hydroxybutyl)azanediyl)bis(hexane-6,1-diyl)bis(2-hexyldecanoate), 1,2-Distearoyl-sn-glycero-3-phosphocholine, cholesterol, dibasic sodium phosphate dihydrate, monobasic potassium phosphate, potassium chloride, sodium chloride, sucrose, and water for injection.
None of these other ingredients has been identified as a likely cause of allergy, Dr. Vander Leek said.
The Pfizer-BioNTech vaccine and some of the candidate COVID-19 vaccines have common reported side effects, including fevers and aches. How do you distinguish an allergic reaction from an expected side effect?
Common responses to vaccines, which can last a couple days to a week or two, are the result of your immune system getting activated, said Zainab Abdurrahman, a clinical immunologist and allergist and assistant clinical professor (adjunct) of pediatrics at McMaster University. A rise in body temperature, redness and swelling around the injection site, and a general sense of tiredness or feeling under the weather are all part of the immune system’s response to try to fight off and stop the spread of infection from what it perceives as a pathogen, Dr. Abdurrahman said.
“Those are all normal things that your body does when it is trying to respond to a threat. And we want it to think what you’re getting in the vaccine is a threat,” so that it can recognize and respond to the actual pathogen, she said.
An allergic reaction, by contrast, is not expected and occurs typically within the first few minutes to an hour of receiving a vaccine, Dr. Abdurrahman said.
Story continues below advertisement
This can involve rashes, breathing problems, swelling and a decrease in blood pressure.
Does having allergies to one substance make you more likely to be allergic to another?
People with asthma, for example, have a higher risk of environmental allergies, Dr. Abdurrahman said, but vaccine allergies are extremely rare. The chances of having anaphylaxis to a vaccine is about one in a million.
“It’s not so much that, [for example], having a peanut allergy is going to increase your risk of having a vaccine allergy; we don’t really see that,” she said.
While no COVID-19 vaccine is approved for children yet, there are trials underway to test them in adolescents. Are children more susceptible to allergies than adults?
There’s no reason to assume children will be more likely to have allergic reactions to the COVID-19 vaccine, Dr. Abdurrahman said.
Story continues below advertisement
Since children do typically experience more redness and fevers when they get other kinds of vaccines than adults, she says she expects it may be more common for them to have expected side effects, like localized pain, redness, swelling and high temperature. Still, there’s no knowing which vaccine children may eventually receive.
What are the options for people who have known allergies to the vaccine ingredients?
It may be possible for them to choose another vaccine that does not have the component to which they are allergic,when others become available, Dr. Vander Leek said. Alternatively, he said, there may be potential ways of desensitizing the body so that they can tolerate receiving it.
Though he noted it is yet unknown whether this could apply to the COVID-19 vaccine, desensitization, which involves gradually building up the dose from an extremely small amount, is used routinely when patients need to take life-saving medications to which they are allergic.
Sign up for the Coronavirus Update newsletter to read the day’s essential coronavirus news, features and explainers written by Globe reporters.
Most job search advice is cookie-cutter. The advice you’re following is almost certainly the same advice other job seekers follow, making you just another candidate following the same script.
In today’s hyper-competitive job market, standing out is critical, a challenge most job seekers struggle with. Instead of relying on generic questions recommended by self-proclaimed career coaches, which often lead to a forgettable interview, ask unique, thought-provoking questions that’ll spark engaging conversations and leave a lasting impression.
Your level of interest in the company and the role.
Contributing to your employer’s success is essential.
You desire a cultural fit.
Here are the top four questions experts recommend candidates ask; hence, they’ve become cliché questions you should avoid asking:
“What are the key responsibilities of this position?”
Most likely, the job description answers this question. Therefore, asking this question indicates you didn’t read the job description. If you require clarification, ask, “How many outbound calls will I be required to make daily?” “What will be my monthly revenue target?”
“What does a typical day look like?”
Although it’s important to understand day-to-day expectations, this question tends to elicit vague responses and rarely leads to a deeper conversation. Don’t focus on what your day will look like; instead, focus on being clear on the results you need to deliver. Nobody I know has ever been fired for not following a “typical day.” However, I know several people who were fired for failing to meet expectations. Before accepting a job offer, ensure you’re capable of meeting the employer’s expectations.
“How would you describe the company culture?”
Asking this question screams, “I read somewhere to ask this question.” There are much better ways to research a company’s culture, such as speaking to current and former employees, reading online reviews and news articles. Furthermore, since your interviewer works for the company, they’re presumably comfortable with the culture. Do you expect your interviewer to give you the brutal truth? “Be careful of Craig; get on his bad side, and he’ll make your life miserable.” “Bob is close to retirement. I give him lots of slack, which the rest of the team needs to pick up.”
Truism: No matter how much due diligence you do, only when you start working for the employer will you experience and, therefore, know their culture firsthand.
“What opportunities are there for professional development?”
When asked this question, I immediately think the candidate cares more about gaining than contributing, a showstopper. Managing your career is your responsibility, not your employer’s.
Cliché questions don’t impress hiring managers, nor will they differentiate you from your competition. To transform your interaction with your interviewer from a Q&A session into a dynamic discussion, ask unique, insightful questions.
Here are my four go-to questions—I have many more—to accomplish this:
“Describe your management style. How will you manage me?”
This question gives your interviewer the opportunity to talk about themselves, which we all love doing. As well, being in sync with my boss is extremely important to me. The management style of who’ll be my boss is a determining factor in whether or not I’ll accept the job.
“What is the one thing I should never do that’ll piss you off and possibly damage our working relationship beyond repair?”
This question also allows me to determine whether I and my to-be boss would be in sync. Sometimes I ask, “What are your pet peeves?”
“When I join the team, what would be the most important contribution you’d want to see from me in the first six months?”
Setting myself up for failure is the last thing I want. As I mentioned, focus on the results you need to produce and timelines. How realistic are the expectations? It’s never about the question; it’s about what you want to know. It’s important to know whether you’ll be able to meet or even exceed your new boss’s expectations.
“If I wanted to sell you on an idea or suggestion, what do you need to know?”
Years ago, a candidate asked me this question. I was impressed he wasn’t looking just to put in time; he was looking for how he could be a contributing employee. Every time I ask this question, it leads to an in-depth discussion.
Other questions I’ve asked:
“What keeps you up at night?”
“If you were to leave this company, who would follow?”
“How do you handle an employee making a mistake?”
“If you were to give a Ted Talk, what topic would you talk about?”
“What are three highly valued skills at [company] that I should master to advance?”
“What are the informal expectations of the role?”
“What is one misconception people have about you [or the company]?”
Your questions reveal a great deal about your motivations, drive to make a meaningful impact on the business, and a chance to morph the questioning into a conversation. Cliché questions don’t lead to meaningful discussions, whereas unique, thought-provoking questions do and, in turn, make you memorable.
Nick Kossovan, a well-seasoned veteran of the corporate landscape, offers “unsweetened” job search advice. You can send Nick your questions to artoffindingwork@gmail.com.
CALGARY – Canadian Natural Resources Ltd. reported a third-quarter profit of $2.27 billion, down from $2.34 billion in the same quarter last year.
The company says the profit amounted to $1.06 per diluted share for the quarter that ended Sept. 30 compared with $1.06 per diluted share a year earlier.
Product sales totalled $10.40 billion, down from $11.76 billion in the same quarter last year.
Daily production for the quarter averaged 1,363,086 barrels of oil equivalent per day, down from 1,393,614 a year ago.
On an adjusted basis, Canadian Natural says it earned 97 cents per diluted share for the quarter, down from an adjusted profit of $1.30 per diluted share in the same quarter last year.
The average analyst estimate had been for a profit of 90 cents per share, according to LSEG Data & Analytics.
This report by The Canadian Press was first published Oct. 31, 2024.
CALGARY – Cenovus Energy Inc. reported its third-quarter profit fell compared with a year as its revenue edged lower.
The company says it earned $820 million or 42 cents per diluted share for the quarter ended Sept. 30, down from $1.86 billion or 97 cents per diluted share a year earlier.
Revenue for the quarter totalled $14.25 billion, down from $14.58 billion in the same quarter last year.
Total upstream production in the quarter amounted to 771,300 barrels of oil equivalent per day, down from 797,000 a year earlier.
Total downstream throughput was 642,900 barrels per day compared with 664,300 in the same quarter last year.
On an adjusted basis, Cenovus says its funds flow amounted to $1.05 per diluted share in its latest quarter, down from adjusted funds flow of $1.81 per diluted share a year earlier.
This report by The Canadian Press was first published Oct. 31, 2024.